134 related articles for article (PubMed ID: 7751056)
1. Transformation of type 1 astrocytes with N-ethyl-N-nitrosourea: establishment of an in vitro system and the role of the p53 gene.
Hiraga S; Arita N; Ohnishi T; Izumoto S; Taki T; Yamamoto H; Higuchi M; Hayakawa T
Glia; 1995 Jan; 13(1):51-63. PubMed ID: 7751056
[TBL] [Abstract][Full Text] [Related]
2. [In vitro ENU-induced carcinogenesis of rat fetal astroglia--biological character of mutant glial cell].
Hiraga S; Arita N; Ohnishi T; Taki T; Yamamoto H; Higuchi M; Hayakawa T
No To Shinkei; 1993 Apr; 45(4):343-7. PubMed ID: 8334019
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
Bögler O; Nagane M; Gillis J; Huang HJ; Cavenee WK
Cell Growth Differ; 1999 Feb; 10(2):73-86. PubMed ID: 10074901
[TBL] [Abstract][Full Text] [Related]
4. In vitro transformation of fetal brain cells from CDF rats exposed in utero to N-ethyl-N-nitrosourea: morphologic and immunologic studies.
Yoshida J; Cravioto H; Ransohoff J
J Natl Cancer Inst; 1980 May; 64(5):1231-9. PubMed ID: 6929021
[TBL] [Abstract][Full Text] [Related]
5. ENU-induced in vitro neoplastic transformation of rat mammary epithelial cells.
Stoica G; Jacobs R; Koestner A; O'Leary M; Welsch C
Anticancer Res; 1991; 11(5):1783-92. PubMed ID: 1837443
[TBL] [Abstract][Full Text] [Related]
6. Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure.
Leonard JR; D'Sa C; Klocke BJ; Roth KA
Oncogene; 2001 Dec; 20(57):8281-6. PubMed ID: 11781843
[TBL] [Abstract][Full Text] [Related]
7. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
[TBL] [Abstract][Full Text] [Related]
8. Promoting effect of 12-O-tetradecanoylphorbol-13-acetate on the in vitro malignant transformation of fetal rat brain cells exposed in utero to ethylnitrosourea.
Kokunai T; Korosue K; Tamaki N; Matsumoto S
Cancer Res; 1986 Mar; 46(3):1377-81. PubMed ID: 3753661
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
Yam JW; Chan KW; Hsiao WL
Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
[TBL] [Abstract][Full Text] [Related]
10. [Effect of tumor promoting agents on the in vitro malignant transformation of the fetal rat brain cells exposed in utero to ethylnitrosourea].
Kokunai T; Kazuyoshi ; Korosue ; Taomoto K; Tamaki N; Matsumoto S
No To Shinkei; 1984 Feb; 36(2):143-50. PubMed ID: 6732984
[TBL] [Abstract][Full Text] [Related]
11. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
12. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice.
Rauth S; Kichina J; Green A; Bratescu L; Das Gupta TK
Anticancer Res; 1994; 14(6B):2457-63. PubMed ID: 7872667
[TBL] [Abstract][Full Text] [Related]
14. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
15. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation.
Bögler O; Huang HJ; Cavenee WK
Cancer Res; 1995 Jul; 55(13):2746-51. PubMed ID: 7796398
[TBL] [Abstract][Full Text] [Related]
16. Effect of estradiol on tumor growth, cell kinetics and p53 oncoprotein expression in human endometrial adenocarcinoma heterotransplanted into nude mice.
Horvath G; Baldetorp B; Fernö M; Johansson M; Nesland J; Tropé C
In Vivo; 1993; 7(5):451-6. PubMed ID: 8110990
[TBL] [Abstract][Full Text] [Related]
17. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of hprt gene mutations in skin fibroblasts of rats exposed in vivo to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea.
Jansen JG; Mohn GR; Vrieling H; van Teijlingen CM; Lohman PH; van Zeeland AA
Cancer Res; 1994 May; 54(9):2478-85. PubMed ID: 8162597
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
20. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
